Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2016

Feb 3, 2016

29745_dirs_2016-02-03_38db0af5-dd99-4007-8f12-fd7389099212.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-02-01

Reporting Person: Harrington Michael J (Senior VP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-01 Common Stock M 9066 Acquired 64109 Direct
2016-02-01 Common Stock F 4194 $79.10 Disposed 59915 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-01 Restricted Stock Unit $ M 9066 Disposed 2016-02-01 Common Stock (9066.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 411 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.